ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

New ACS Structure Proposed, approved

August 6, 1993

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977